Fig. 2From: Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapyKaplan‒Meier survival curves of breast cancer patients with nonpCR for OS (A) and DFS (B) stratified by mSIS. The survival curves of breast cancer patients with pCR for OS (C) and DFS (D) stratified by mSISBack to article page